Old | New | Differences | |
---|---|---|---|
1 | 1 | ||
2 | 2 | ||
3 | 3 | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
4 | 4 | [Brackets] indicate matter deleted from existing law. | |
5 | - | Underlining indicates amendments to bill. | |
6 | - | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
7 | - | amendment. | |
8 | 5 | *sb0094* | |
9 | 6 | ||
10 | 7 | SENATE BILL 94 | |
11 | 8 | J1 5lr1471 | |
12 | - | (PRE–FILED) | |
9 | + | (PRE–FILED) | |
13 | 10 | By: Senator Ellis | |
14 | 11 | Requested: October 29, 2024 | |
15 | 12 | Introduced and read first time: January 8, 2025 | |
16 | 13 | Assigned to: Finance | |
17 | - | Committee Report: Favorable with amendments | |
18 | - | Senate action: Adopted with floor amendments | |
19 | - | Read second time: February 7, 2025 | |
20 | 14 | ||
21 | - | ||
15 | + | A BILL ENTITLED | |
22 | 16 | ||
23 | 17 | AN ACT concerning 1 | |
24 | 18 | ||
25 | - | Maryland Medical Assistance Program – | |
26 | - | ||
19 | + | Maryland Medical Assistance Program – Self–Measured Blood Pressure 2 | |
20 | + | Monitoring 3 | |
27 | 21 | ||
28 | 22 | FOR the purpose of requiring, beginning on a certain date, the Maryland Medical 4 | |
29 | 23 | Assistance Program to provide coverage for self–measured blood pressure 5 | |
30 | 24 | monitoring for certain eligible Program recipients; requiring the Program to develop 6 | |
31 | 25 | and implement a certain education campaign; and generally relating to 7 | |
32 | 26 | self–measured blood pressure monitoring under the Maryland Medical Assistance 8 | |
33 | 27 | Program. 9 | |
34 | 28 | ||
35 | 29 | BY repealing and reenacting, without amendments, 10 | |
36 | 30 | Article – Health – General 11 | |
37 | 31 | Section 15–101(h), (j), and (l) and 15–103(a)(1) 12 | |
38 | 32 | Annotated Code of Maryland 13 | |
39 | 33 | (2023 Replacement Volume and 2024 Supplement) 14 | |
40 | 34 | ||
41 | 35 | BY repealing and reenacting, with amendments, 15 | |
42 | 36 | Article – Health – General 16 | |
43 | 37 | Section 15–103(a)(2)(xxiii) and (xxiv) 17 | |
44 | 38 | Annotated Code of Maryland 18 | |
45 | 39 | (2023 Replacement Volume and 2024 Supplement) 19 | |
46 | 40 | ||
47 | 41 | BY adding to 20 | |
48 | - | Article – Health – General 21 2 SENATE BILL 94 | |
42 | + | Article – Health – General 21 | |
43 | + | Section 15–103(a)(2)(xxv) and 15–141.6 22 | |
44 | + | Annotated Code of Maryland 23 | |
45 | + | (2023 Replacement Volume and 2024 Supplement) 24 | |
46 | + | ||
47 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 25 | |
48 | + | That the Laws of Maryland read as follows: 26 2 SENATE BILL 94 | |
49 | 49 | ||
50 | 50 | ||
51 | - | Section 15–103(a)(2)(xxv) and 15–141.6 1 | |
52 | - | Annotated Code of Maryland 2 | |
53 | - | (2023 Replacement Volume and 2024 Supplement) 3 | |
54 | 51 | ||
55 | - | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 4 | |
56 | - | That the Laws of Maryland read as follows: 5 | |
52 | + | Article – Health – General 1 | |
57 | 53 | ||
58 | - | ||
54 | + | 15–101. 2 | |
59 | 55 | ||
60 | - | ||
56 | + | (h) “Program” means the Maryland Medical Assistance Program. 3 | |
61 | 57 | ||
62 | - | (h) “Program” means the Maryland Medical Assistance Program. 8 | |
58 | + | (j) “Self–measured blood pressure monitoring” means the regular measurement 4 | |
59 | + | of blood pressure by the patient outside the clinical setting, either at home or elsewhere, 5 | |
60 | + | requiring the use of a home blood pressure measurement device by the patient. 6 | |
63 | 61 | ||
64 | - | ( | |
65 | - | ||
66 | - | ||
62 | + | (l) “Validated home blood pressure monitor” means a blood pressure 7 | |
63 | + | measurement device that has been validated for accuracy and is listed in the U.S. Blood 8 | |
64 | + | Pressure Validated Device Listing. 9 | |
67 | 65 | ||
68 | - | (l) “Validated home blood pressure monitor” means a blood pressure 12 | |
69 | - | measurement device that has been validated for accuracy and is listed in the U.S. Blood 13 | |
70 | - | Pressure Validated Device Listing. 14 | |
66 | + | 15–103. 10 | |
71 | 67 | ||
72 | - | 15–103. 15 | |
68 | + | (a) (1) The Secretary shall administer the Maryland Medical Assistance 11 | |
69 | + | Program. 12 | |
73 | 70 | ||
74 | - | (a) (1) The Secretary shall administer the Maryland Medical Assistance 16 | |
75 | - | Program. 17 | |
71 | + | (2) The Program: 13 | |
76 | 72 | ||
77 | - | (2) The Program: 18 | |
73 | + | (xxiii) Beginning on July 1, 2025, shall provide, subject to the 14 | |
74 | + | limitations of the State budget, and as permitted by federal law, coverage for biomarker 15 | |
75 | + | testing in accordance with § 15–859 of the Insurance Article; [and] 16 | |
78 | 76 | ||
79 | - | (xxiii) Beginning on July 1, 2025, shall provide, subject to the 19 | |
80 | - | limitations of the State budget, and as permitted by federal law, coverage for biomarker 20 | |
81 | - | testing in accordance with § 15–859 of the Insurance Article; [and] 21 | |
77 | + | (xxiv) Beginning on January 1, 2025, shall provide coverage for 17 | |
78 | + | prostheses in accordance with § 15–844 of the Insurance Article; AND 18 | |
82 | 79 | ||
83 | - | (xxiv) Beginning on January 1, 2025, shall provide coverage for 22 | |
84 | - | prostheses in accordance with § 15–844 of the Insurance Article; AND 23 | |
80 | + | (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE , 19 | |
81 | + | SUBJECT TO T HE LIMITATIONS OF TH E STATE BUDGET , AND AS PERMITTED BY 20 | |
82 | + | FEDERAL LAW , COVERAGE FOR SELF–MEASURED BLOOD PRESS URE MONITORING 21 | |
83 | + | FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS 22 | |
84 | + | SUBTITLE. 23 | |
85 | 85 | ||
86 | - | (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE , 24 | |
87 | - | SUBJECT TO THE LIMIT ATIONS OF THE STATE BUDGET , AND AS PERMITTED BY 25 | |
88 | - | FEDERAL LAW , COVERAGE FOR SELF –MEASURE D BLOOD PRESSURE MON ITORING 26 | |
89 | - | FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS 27 | |
90 | - | SUBTITLE. 28 | |
86 | + | 15–141.6. 24 | |
91 | 87 | ||
92 | - | 15–141.6. 29 | |
88 | + | (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS 25 | |
89 | + | INDICATED. 26 | |
93 | 90 | ||
94 | - | (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS 30 | |
95 | - | INDICATED. 31 | |
91 | + | (2) “ELIGIBLE PROGRAM RECIPIENT ” MEANS A PROGRAM 27 | |
92 | + | RECIPIENT WHO : 28 | |
93 | + | ||
94 | + | (I) IS PREGNANT; 29 | |
96 | 95 | SENATE BILL 94 3 | |
97 | 96 | ||
98 | 97 | ||
99 | - | (2) “ELIGIBLE PROGRAM, “ELIGIBLE PROGRAM RECIPIENT” MEANS 1 | |
100 | - | A PROGRAM RECIPIENT WHO : 2 | |
98 | + | (II) IS POSTPARTUM ; OR 1 | |
101 | 99 | ||
102 | - | ( | |
100 | + | (III) HAS BEEN DIAGNOSED WI TH: 2 | |
103 | 101 | ||
104 | - | | |
102 | + | 1. CHRONIC KIDNEY DISEAS E; 3 | |
105 | 103 | ||
106 | - | | |
104 | + | 2. DIABETES; 4 | |
107 | 105 | ||
108 | - | | |
106 | + | 3. HEART DISEASE; OR 5 | |
109 | 107 | ||
110 | - | | |
108 | + | 4. A CARDIOMETABOLIC DISE ASE. 6 | |
111 | 109 | ||
112 | - | ||
110 | + | (3) “HEALTH CARE PROVIDER ” MEANS: 7 | |
113 | 111 | ||
114 | - | 4. (IV) A CARDIOMETABOLIC DISE ASE. 9 | |
112 | + | (I) A PERSON WHO IS LICENS ED, CERTIFIED, OR OTHERWISE 8 | |
113 | + | AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH 9 | |
114 | + | CARE IN THE ORDINARY COURSE OF BUSINES S OR PRACTICE OF A P ROFESSION, OR 10 | |
115 | + | IN AN APPROVED EDUCA TION OR TRAINING PRO GRAM; OR 11 | |
115 | 116 | ||
116 | - | (3) “HEALTH CARE PROVIDER ” MEANS: 10 | |
117 | + | (II) A COMMUNITY HEALTH WOR KER CERTIFIED UNDER TITLE 12 | |
118 | + | 13, SUBTITLE 37 OF THIS ARTICLE. 13 | |
117 | 119 | ||
118 | - | (I) A PERSON WHO IS LICENS ED, CERTIFIED, OR OTHERWISE 11 | |
119 | - | AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH 12 | |
120 | - | CARE IN THE ORDINARY COURSE OF BUSINESS O R PRACTICE OF A PROF ESSION, OR 13 | |
121 | - | IN AN APPROVED EDUCA TION OR TRAINING PROGRAM ; OR 14 | |
120 | + | (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF–MEASURED 14 | |
121 | + | BLOOD PRESSURE MONIT ORING FOR ALL ELIGIBLE PROGRAM RECIPIENTS , 15 | |
122 | + | INCLUDING: 16 | |
122 | 123 | ||
123 | - | ( | |
124 | - | ||
124 | + | (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 17 | |
125 | + | MONITORS; AND 18 | |
125 | 126 | ||
126 | - | (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF –MEASURED 17 | |
127 | - | BLOOD PRESSURE MONIT ORING FOR ALL ELIGIB LE PROGRAM RECIPIENTS , 18 | |
128 | - | INCLUDING: 19 | |
127 | + | (2) REIMBURSEMENT OF HEAL TH CARE PROVIDER AND OTHER STAFF 19 | |
128 | + | TIME USED FOR PATIEN T TRAINING, TRANSMISSION OF BLO OD PRESSURE DATA , 20 | |
129 | + | INTERPRETATION OF BL OOD PRESSURE READING S AND REPORTING , REMOTE 21 | |
130 | + | PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 22 | |
131 | + | EDUCATIONAL MATERIAL S OR CLASSES. 23 | |
129 | 132 | ||
130 | - | (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 20 | |
131 | - | MONITORS; AND 21 | |
133 | + | (C) THE PROGRAM SHALL DEVELOP AND IMPLEMENT AN EDUCATION 24 | |
134 | + | CAMPAIGN TO INFORM ELIGIBLE PROGRAM RECIPIENTS AND HEALTH CARE 25 | |
135 | + | PROVIDERS ABOUT THE BENEFITS A ND USAGE OF BLOOD PR ESSURE MONITORING 26 | |
136 | + | TECHNOLOGY AND THE AVAILABILITY OF ASSISTANCE WITH SETUP AND 27 | |
137 | + | TROUBLESHOOTING . 28 | |
132 | 138 | ||
133 | - | (2) REIMBURSEMENT OF HEAL TH CARE PROVIDER AND OTHER STAFF 22 | |
134 | - | TIME USED FOR PATIEN T TRAINING, TRANSMISSION OF BLOO D PRESSURE DATA , 23 | |
135 | - | INTERPRETATION OF BL OOD PRESSURE READING S AND REPORTING , REMOTE 24 | |
136 | - | PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 25 | |
137 | - | EDUCATIONAL MATERIAL S OR CLASSES. 26 | |
138 | - | ||
139 | - | (C) THE PROGRAM SHALL DEVELOP AND IMPLEMENT AN EDU CATION 27 | |
140 | - | CAMPAIGN TO INFORM E LIGIBLE PROGRAM RECIPIENTS AN D HEALTH CARE 28 | |
141 | - | PROVIDERS ABOUT THE BENEFITS AN D USAGE OF BLOOD PRE SSURE MONITORING 29 4 SENATE BILL 94 | |
139 | + | (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE 29 | |
140 | + | DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND 30 4 SENATE BILL 94 | |
142 | 141 | ||
143 | 142 | ||
144 | - | TECHNOLOGY AND THE A VAILABILITY OF ASSIS TANCE WITH SETUP AND 1 | |
145 | - | TROUBLESHOOTING . 2 | |
143 | + | THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN 1 | |
144 | + | ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT 2 | |
145 | + | INCLUDES: 3 | |
146 | 146 | ||
147 | - | (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE 3 | |
148 | - | DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND 4 | |
149 | - | THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN 5 | |
150 | - | ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT 6 | |
151 | - | INCLUDES: 7 | |
147 | + | (1) THE TOTAL NUMBER OF ELIGIBLE PROGRAM RE CIPIENTS WHO 4 | |
148 | + | RECEIVED BLOOD PRESSURE MONIT ORS UNDER THIS SECTION DURING THE 5 | |
149 | + | IMMEDIATELY PRECEDIN G 12–MONTH PERIOD ; 6 | |
152 | 150 | ||
153 | - | (1) THE TOTAL NUMBER OF E LIGIBLE PROGRAM RECIPIENTS WH O 8 | |
154 | - | RECEIVED BLOOD PRESS URE MONITORS UNDER T HIS SECTION DURING T HE 9 | |
155 | - | IMMEDIATELY PRECEDING 12–MONTH PERIOD ; 10 | |
151 | + | (2) THE OUTCOMES ASSOCIATED WITH THE USE OF THE HOME BLOOD 7 | |
152 | + | PRESSURE MONITORS UNDER THIS SECTION ; AND 8 | |
156 | 153 | ||
157 | - | (2) THE OUTCOMES ASSOCIAT ED WITH THE USE OF T HE HOME BLOOD 11 | |
158 | - | PRESSURE MONITORS UN DER THIS SECTION ; AND 12 | |
154 | + | (3) ANY COST SAVINGS ACHIEVED BY THE PROGRAM DURING THE 9 | |
155 | + | IMMEDIATELY PRECEDIN G FISCAL YEAR ASSOCIATED WITH THE USE OF THE HOME 10 | |
156 | + | BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION. 11 | |
159 | 157 | ||
160 | - | (3) ANY COST SAVINGS ACHI EVED BY THE PROGRAM DURING THE 13 | |
161 | - | IMMEDIATELY PRECEDIN G FISCAL YEAR ASSOCI ATED WITH THE USE OF THE HOME 14 | |
162 | - | BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION. 15 | |
163 | - | ||
164 | - | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 16 | |
165 | - | 1, 2025. 17 | |
166 | - | ||
167 | - | ||
168 | - | ||
169 | - | ||
170 | - | Approved: | |
171 | - | ________________________________________________________________________________ | |
172 | - | Governor. | |
173 | - | ________________________________________________________________________________ | |
174 | - | President of the Senate. | |
175 | - | ________________________________________________________________________________ | |
176 | - | Speaker of the House of Delegates. | |
158 | + | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 12 | |
159 | + | 1, 2025. 13 |